In the BioHarmony Drug Report Database
Rifabutin
Mycobutin (rifabutin) is a small molecule pharmaceutical. Rifabutin was first approved as Mycobutin on 1992-12-23. It is used to treat mycobacterium avium-intracellulare infection, mycobacterium infections, and pulmonary tuberculosis in the USA.
Trade Name
|
Mycobutin |
|---|---|
Common Name
|
rifabutin |
ChEMBL ID
|
CHEMBL444633 |
Indication
|
mycobacterium avium-intracellulare infection, mycobacterium infections, pulmonary tuberculosis |
Drug Class
|
Antibiotics (rifamycin derivatives) |
Image (chem structure or protein)